| Submit your comments on this article |
| -Short Attention Span Theater- |
| COVID-19: France cancels its order for molnupiravir the same day US FDA issues EUA for it |
| 2021-12-24 |
[FoxBusinessNews] FDA issues EUA to authorize second ORAL COVID-19 antiviral, Merck's molnupiravir. The molnupiravir pill is cleared for use by adults 18 and older who have tested positive for COVID-19 and are at high risk of hospitalization or death
PARIS/MILAN, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's (MRK.N) COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's (PFE.N) competing drug before the end of January, the health minister said on Wednesday.
France is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.
From an article in Nature.com:
Merck's COVID pill loses its lustre: what that means for the pandemic
Molnupiravir was initially heralded by public-health officials as a game-changer for COVID-19, but full clinical-trial data showed lower-than-expected efficacy. |
| Posted by:Bubba Lover of the Faeries8843 |